8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 2, 2010

NATIONWIDE HEALTH PROPERTIES, INC.
(Exact name of registrant as specified in its charter)

Maryland	1-9028	95-3997619
(State or other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

610 Newport Center Drive, Suite 1150, Newport Beach, CA	92660
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number, including area code: (949) 718-4400

(Former name or former address if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02 Results of Operations and Financial Condition.

On August 2, 2010, we issued a press release, which sets forth our results of operations for the quarter and six months ended June 30, 2010. The press release referred to a supplemental information package that is available on our website, free of charge, at www.nhp-reit.com. A copy of the press release and the supplemental information package are attached hereto as Exhibits 99.1 and 99.2, respectively, and are incorporated herein by this reference.

Such information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is not incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number	Description
99.1	Press release dated August 2, 2010.
99.2	Supplemental information package for the quarter and six months ended June 30, 2010.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	NATIONWIDE HEALTH PROPERTIES, INC.
Date: August 2, 2010	By:	/s/ Abdo H. Khoury
		Abdo H. Khoury Executive Vice President and Chief Financial & Portfolio Officer

EX-99.1

Exhibit 99.1

NATIONWIDE HEALTH PROPERTIES, INC.
REPORTS 2010 SECOND QUARTER RESULTS

• Completed $194 Million of Investments in the Second Quarter of 2010

• Raising FFO Guidance on the High End of the Range by $0.08 per Share to $2.25

• Second Quarter 2010 Revenue Increased 13% Over Second Quarter 2009

NEWPORT BEACH, CA, —(Marketwire– August 2, 2010) — Nationwide Health Properties, Inc. (NYSE: NHP) today announced results of operations for the second quarter ended June 30, 2010. Contemporaneously with this press release, the Company filed its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2010 with the Securities and Exchange Commission.

“We maintained the first quarter momentum with $194 million of investments in the second quarter. The initial yield on the $578 million of investments made in the first six months of the year is 8.5%,” commented Douglas M. Pasquale, NHP’s Chairman and Chief Executive Officer. “Our liquidity position remains strong with $173 million in cash at quarter end and the extension of the maturity date of our $700 million credit facility to December 15, 2011. NHP’s outstanding credit statistics and available capital facilitate our ability to add accretive investments in the coming quarters,” Mr. Pasquale added.

SECOND QUARTER 2010 RESULTS OF OPERATIONS

The following table presents selected unaudited financial information for the second quarter and six months ended June 30, 2010 as compared to the same periods of 2009:

Selected Financial Data
($ in thousands, except per share amounts)

	Three Months Ended June 30,
	2010		2009		$ Change			% Change
Revenue	$	109,248	$	96,769	$	12,479			12.9	%
Income from Continuing Operations	$	33,011	$	34,542	$	(1,531	)		-4.4	%
Net Income Attributable to NHP Common Stockholders	$	37,169	$	33,299	$	3,870			11.6	%
Net Income Attributable to NHP Common Stockholders Per Diluted Share	$	0.30	$	0.31	$	(0.01	)		-3.2	%
Diluted FFO	$	68,072	$	66,630	$	1,442			2.2	%
Adjusted Diluted FFO	$	69,699	$	62,066	$	7,633			12.3	%
Diluted FFO Per Share	$	0.55	$	0.61	$	(0.06	)		-9.8	%
Adjusted Diluted FFO Per Share	$	0.57	$	0.57	$	—			0.0	%
Diluted FAD	$	66,327	$	66,242	$	85			0.1	%
Adjusted Diluted FAD	$	67,954	$	61,678	$	6,276			10.2	%
Diluted FAD Per Share	$	0.54	$	0.61	$	(0.07	)		-11.5	%
Adjusted Diluted FAD Per Share	$	0.55	$	0.57	$	(0.02	)		-3.5	%

	Six Months Ended June 30,
	2010		2009		$ Change			% Change
Revenue	$	211,443	$	193,477	$	17,966			9.3	%
Income from Continuing Operations	$	64,073	$	63,673	$	400			0.6	%
Net Income Attributable to NHP Common Stockholders	$	68,598	$	82,453	$	(13,855	)		-16.8	%
Net Income Attributable to NHP Common Stockholders Per Diluted Share	$	0.56	$	0.78	$	(0.22	)		-28.2	%
Diluted FFO	$	132,263	$	128,197	$	4,066			3.2	%
Adjusted Diluted FFO	$	134,638	$	123,633	$	11,005			8.9	%
Diluted FFO Per Share	$	1.09	$	1.18	$	(0.09	)		-7.6	%
Adjusted Diluted FFO Per Share	$	1.11	$	1.14	$	(0.03	)		-2.6	%
Diluted FAD	$	130,594	$	127,668	$	2,926			2.3	%
Adjusted Diluted FAD	$	132,969	$	123,104	$	9,865			8.0	%
Diluted FAD Per Share	$	1.08	$	1.18	$	(0.10	)		-8.5	%
Adjusted Diluted FAD Per Share	$	1.10	$	1.14	$	(0.04	)		-3.5	%

2

NON-GAAP FINANCIAL MEASURES

Diluted Funds From Operations (“FFO”) and Diluted Funds Available for Distribution (“FAD”) are non-GAAP measures that we believe are important to understanding our operations. We believe diluted FFO is an important supplemental measure of operating performance because it excludes the effects of depreciation and amortization and gains (losses) from sales of facilities (both of which are based on historical costs and which may be of limited relevance in evaluating current performance). We believe diluted FAD is an important supplemental measure of operating performance because, like diluted FFO, it excludes the effects of depreciation and amortization and gains (losses) from sales of facilities (both of which are based on historical costs and which may be of limited relevance in evaluating current performance). It also excludes straight-lined rent and other non-cash items that have become more significant for us and our competitors over the last several years. We believe that net income is the most directly comparable GAAP measure to diluted FFO and diluted FAD. Reconciliations between net income and diluted FFO and net income and diluted FAD are included in the accompanying financial data. For guidance, we have also included in the accompanying financial data reconciliations between net income per share and diluted FFO and diluted FAD per share. We have also included adjusted diluted FFO and adjusted diluted FAD amounts which exclude acquisition costs and the recognition of a net gain on re-measurement of equity interest upon acquisition in 2010 and gains on debt extinguishments in 2010 and 2009.

SECOND QUARTER 2010 INVESTMENT ACTIVITY

Investment Activity 2010
($ in thousands)

	Q1			Q2			Q3			YTD
Investment	Total			Total			To Date			Total
Assisted and Independent Living Facilities
Number					5			2			7
Investment				$	6,000		$	31,000		$	37,000
Initial Yield					8.8	%		8.0	%		8.1	%
Skilled Nursing Facilities
Number					11			4			15
Investment				$	130,000		$	29,000		$	159,000
Initial Yield					9.1	%		9.8	%		9.2	%
Medical Office Buildings
Number		33			8						41
Investment	$	380,000		$	46,000					$	426,000
Initial Yield		8.2	%		9.3	%					8.4	%
Total
Number		33			24			6			63
Investment	$	380,000		$	182,000		$	60,000		$	622,000
Initial Yield		8.2	%		9.1	%		8.9	%		8.5	%

Additionally in the second quarter of 2010, we invested approximately $6.0 million in revenue producing capital expenditures at a blended yield of 8.4% for a total of $10.0 million at a blended yield of 8.4% in the first six months of the year, and funded two unsecured loans totaling $5.5 million at a blended rate of 9.3%.

3

SECOND QUARTER 2010 FINANCING TRANSACTIONS

At-The-Market Equity Offering Program 2010
(in thousands, except price per share)

	Q1		Q2		Q3		YTD
	Total		Total		To Date		Total
Number of Shares		1,269		3,789		1,655		6,713
Average Price per Share	$	35.58	$	35.69	$	37.03	$	36.00
Net Proceeds	$	44,673	$	133,820	$	60,644	$	239,137

In June 2010, we exercised our option to extend our $700 million credit facility maturity to December 15, 2011.

Subsequent to June 30, 2010, we paid off $64.3 million of mortgage debt that matured.

2010 GUIDANCE

Guidance for Year Ended December 31, 2010

	Guidance Dates						Change from
	Initial		Q1 Results		Current		Previous
Metric	Guidance		Update		Update		Update
Adjusted Diluted FFO Per Share
High End	$	2.09	$	2.17	$	2.25	$	0.08
Low End	$	2.05	$	2.14	$	2.23	$	0.09
Adjusted Diluted FAD Per Share
High End	$	2.05	$	2.13	$	2.19	$	0.06
Low End	$	2.01	$	2.10	$	2.17	$	0.07

Our guidance includes shares issued through our at-the-market equity offering program, mortgage debt payoffs and closed acquisitions and dispositions through August 2, 2010 and excludes any other acquisitions, investments, impairments or capital transactions that may occur in the remainder of 2010.

4

CONFERENCE CALL INFORMATION

We have scheduled a conference call and webcast on Tuesday, August 3, 2010 at 11:00 a.m. Pacific Time (2:00 p.m. Eastern Time) to discuss these results. The conference call is accessible by dialing 800-573-4752 and referencing conference ID number 96821760 or by logging on to our website at http://www.nhp-reit.com. The international dial-in number is 617-224-4324. The earnings release and any additional financial information that may be discussed on the conference call and webcast will also be available at the same location on our website. A digitized replay of the conference call will be available from 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) that day until 9:00 p.m. Pacific Time (Midnight Eastern Time) on September 3, 2010. Callers can access the replay by dialing 888-286-8010 or 617-801-6888 and entering conference ID number 78550756. Webcast replays will also be available on our website for at least 12 months following the conference call. Our supplemental information package for the quarter ended June 30, 2010 is available on our website, free of charge, at http://www.nhp-reit.com by selecting “Investor Relations” followed by “Financial Information” and is included in our Current Report on Form 8-K filed August 2, 2010 with the SEC also containing this release. Shareholders may receive free of charge a complete set of our audited financial statements upon request.

ABOUT NATIONWIDE HEALTH PROPERTIES, INC.

Nationwide Health Properties, Inc. is a real estate investment trust (REIT) that invests primarily in healthcare real estate in the United States. As of June 30, 2010, the Company’s portfolio of properties, including mortgage loans and properties owned by unconsolidated joint ventures, totaled 628 properties among the following segments: 283 senior housing facilities, 206 skilled nursing facilities, 120 medical office buildings, 11 continuing care retirement communities, 7 specialty hospitals and 1 asset held for sale. For more information on Nationwide Health Properties, Inc., visit our website at http://www.nhp-reit.com.

FORWARD LOOKING STATEMENTS

Certain information contained in this release includes forward-looking statements. Forward-looking statements include statements regarding our expectations, beliefs, intentions, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements which are not statements of historical facts. These statements may be identified, without limitation, by the use of forward-looking terminology such as “may,” “will,” “anticipates,” “expects,” “believes,” “intends,” “should” or comparable terms or the negative thereof. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those described in the statements. Risks and uncertainties associated with our business include (without limitation) the following: deterioration in the operating results or financial condition, including bankruptcies, of our tenants; non-payment or late payment of rent, interest or loan principal amounts by our tenants; our reliance on one tenant for a significant percentage of our revenue; occupancy levels at certain facilities; our level of indebtedness; changes in the ratings of our debt securities; maintaining compliance with our debt covenants; access to the capital markets and the cost and availability of capital; the effect of healthcare reform legislation or government regulations, including changes in the reimbursement levels under the Medicare and Medicaid programs; the general distress of the healthcare industry; increasing competition in our business sector; the effect of economic and market conditions and changes in interest rates; the amount and yield of any additional investments; risks associated with acquisitions, including our ability to identify and complete favorable transactions, delays or failures in obtaining third party consents or approvals, the failure to achieve perceived benefits,

5

unexpected costs or liabilities and potential litigation; the ability of our tenants to pay contractual rent and/or interest escalations in future periods; the ability of our tenants to obtain and maintain adequate liability and other insurance; our ability to attract new tenants for certain facilities; our ability to sell certain facilities for their book value; our ability to retain key personnel; potential liability under environmental laws; the possibility that we could be required to repurchase some of our senior notes; changes in or inadvertent violations of tax laws and regulations and other factors that can affect our status as a real estate investment trust; and other factors discussed from time to time in our news releases, public statements and/or filings with the Securities and Exchange Commission, especially the “Risk Factors” sections of our Annual and Quarterly Reports on Forms 10-K and 10-Q. Forward-looking information is provided by us pursuant to the safe harbor established under the Private Securities Litigation Reform Act of 1995 and should be evaluated in the context of these factors. We disclaim any intent or obligation to update these forward-looking statements.

Contact:
Abdo H. Khoury
Chief Financial and Portfolio Officer
Nationwide Health Properties, Inc.
(949) 718-4400

***Financial Tables to Follow***

6

NATIONWIDE HEALTH PROPERTIES, INC.
CONSOLIDATED INCOME STATEMENTS
(In thousands, except per share data)
(Unaudited)

	Three Months Ended June 30,					Six Months Ended June 30,
	2010		2009			2010		2009
Revenue:
Triple-net lease rent	$	76,236	$	72,674		$	149,783	$	145,961
Medical office building operating rent		27,124		17,437			48,809		34,523
		103,360		90,111			198,592		180,484
Interest and other income		5,888		6,658			12,851		12,993
		109,248		96,769			211,443		193,477
Expenses:
Interest expense		24,452		23,247			48,042		47,319
Depreciation and amortization		33,832		30,617			65,723		61,370
General and administrative		7,384		6,973			14,369		13,904
Acquisition costs		1,627		—			3,070		—
Medical office building operating expenses		10,270		7,128			18,917		13,962
		77,565		67,965			150,121		136,555
Operating income		31,683		28,804			61,322		56,922
Income from unconsolidated joint ventures		1,328		1,174			2,676		2,187
Gain on debt extinguishment		—		4,564			75		4,564
Income from continuing operations		33,011		34,542			64,073		63,673
Discontinued operations:
Gains on sale of facilities, net		3,779		—			3,801		21,152
Income from discontinued operations		232		284			387		634
		4,011		284			4,188		21,786
Net income		37,022		34,826			68,261		85,459
Net loss (income) attributable to noncontrolling interests		147		(75	)		337		(102	)
Net income attributable to NHP		37,169		34,751			68,598		85,357
Preferred stock dividends		—		(1,452	)		—		(2,904	)
Income available to NHP common stockholders	$	37,169	$	33,299		$	68,598	$	82,453
Basic earnings per share (EPS):
Income from continuing operations attributable to NHP common stockholders	$	0.28	$	0.32		$	0.54	$	0.59
Discontinued operations attributable to NHP common stockholders		0.03		—			0.03		0.21
Net income attributable to NHP common stockholders	$	0.31	$	0.32		$	0.57	$	0.80
Diluted EPS:
Income from continuing operations attributable to NHP common stockholders	$	0.27	$	0.31		$	0.53	$	0.57
Discontinued operations attributable to NHP common stockholders		0.03		—			0.03		0.21
Net income attributable to NHP common stockholders	$	0.30	$	0.31		$	0.56	$	0.78
Weighted average shares outstanding for EPS:
Basic		119,883		103,089			118,473		102,724
Diluted		122,599		105,182			121,039		104,797

7

NATIONWIDE HEALTH PROPERTIES, INC.
RECONCILIATIONS OF NET INCOME TO NON-GAAP FINANCIAL MEASURES
(In thousands, except per share data)
(Unaudited)

Reconciliation of Net Income to Adjusted Diluted FFO

	Three Months Ended June 30,						Six Months Ended June 30,
	2010			2009			2010			2009
Net income	$	37,022		$	34,826		$	68,261		$	85,459
Preferred stock dividends		—			(1,452	)		—			(2,904	)
Net loss (income) attributable to noncontrolling interests		147			(75	)		337			(102	)
Real estate related depreciation and amortization		33,501			30,567			65,046			61,374
Depreciation in income from unconsolidated joint ventures		1,181			1,312			2,420			2,618
Gains on sale of facilities, net		(3,779	)		—			(3,801	)		(21,152	)
FFO available to NHP common stockholders		68,072			65,178			132,263			125,293
Series B preferred dividend add-back		—			1,452			—			2,904
Diluted FFO		68,072			66,630			132,263			128,197
Acquisition costs		1,627			—			3,070			—
Gain on extinguishment of debt		—			(4,564	)		(75	)		(4,564	)
Gain on re-measurement of equity interest upon acquisition, net		—			—			(620	)		—
Adjusted diluted FFO	$	69,699		$	62,066		$	134,638		$	123,633
Weighted average shares outstanding for diluted FFO:
Diluted weighted average shares outstanding (1)		122,701			105,241			121,146			104,848
Series B preferred stock conversion add-back if not already converted		—			3,368			154			3,363
Fully diluted weighted average shares outstanding		122,701			108,609			121,300			108,211
Diluted FFO per share	$	0.55		$	0.61		$	1.09		$	1.18
Adjusted diluted FFO per share	$	0.57		$	0.57		$	1.11		$	1.14
Dividends declared per common share	$	0.45		$	0.44		$	0.89		$	0.88
Adjusted diluted FFO payout ratio		79	%		77	%		80	%		77	%
Adjusted diluted FFO coverage		1.27			1.30			1.25			1.30

(1) Diluted weighted average shares outstanding includes the effect of all participating and non-participating share-based payment awards which for us consists of stock options and other share-based payment awards if the effect is dilutive. The dilutive effect of all share-based payment awards is calculated using the treasury stock method. Additionally, our redeemable OP units are included as if converted to common stock on a one-for-one basis.

8

NATIONWIDE HEALTH PROPERTIES, INC.
RECONCILIATIONS OF NET INCOME TO NON-GAAP FINANCIAL MEASURES
(In thousands, except per share data)
(Unaudited)

Reconciliation of Net Income to Adjusted Diluted FAD

	Three Months Ended June 30,						Six Months Ended June 30,
	2010			2009			2010			2009
Net income	$	37,022		$	34,826		$	68,261		$	85,459
Preferred stock dividends		—			(1,452	)		—			(2,904	)
Net loss (income) attributable to noncontrolling interests		147			(75	)		337			(102	)
Real estate related depreciation and amortization		33,501			30,567			65,046			61,374
Gains on sale of facilities, net		(3,779	)		—			(3,801	)		(21,152	)
Straight-lined rent		(3,511	)		(1,599	)		(5,198	)		(3,188	)
Amortization of intangible assets and liabilities		150			(48	)		91			(271	)
Non-cash stock-based compensation expense		1,832			1,837			3,426			3,410
Deferred financing cost amortization		829			756			1,674			1,570
Lease commissions and tenant and capital improvements		(1,066	)		(1,343	)		(1,703	)		(2,069	)
Unconsolidated joint ventures:
Real estate related depreciation and amortization		1,181			1,312			2,420			2,618
Straight-lined rent		(1	)		(12	)		(2	)		(23	)
Deferred finance cost amortization		22			21			43			42
FAD available to NHP common stockholders		66,327			64,790			130,594			124,764
Series B preferred dividends		—			1,452			—			2,904
Diluted FAD		66,327			66,242			130,594			127,668
Acquisition costs		1,627			—			3,070			—
Gain on extinguishment of debt		—			(4,564	)		(75	)		(4,564	)
Gain on re-measurement of equity interest upon acquisition, net		—			—			(620	)		—
Adjusted diluted FAD	$	67,954		$	61,678		$	132,969		$	123,104
Weighted average shares outstanding for diluted FAD:
Diluted weighted average shares outstanding (1)		122,701			105,241			121,146			104,848
Series B preferred stock add-back if not already converted		—			3,368			154			3,363
Fully diluted weighted average shares outstanding		122,701			108,609			121,300			108,211
Diluted FAD per share	$	0.54		$	0.61		$	1.08		$	1.18
Adjusted diluted FAD per share	$	0.55		$	0.57		$	1.10		$	1.14
Dividends declared per common share	$	0.45		$	0.44		$	0.89		$	0.88
Adjusted diluted FAD payout ratio		82	%		77	%		81	%		77	%
Adjusted diluted FAD coverage		1.22			1.30			1.24			1.30

(1) Diluted weighted average shares outstanding includes the effect of all participating and non-participating share-based payment awards which for us consists of stock options and other share-based payment awards if the effect is dilutive. The dilutive effect of all share-based payment awards is calculated using the treasury stock method. Additionally, our redeemable OP units are included as if converted to common stock on a one-for-one basis.

9

NATIONWIDE HEALTH PROPERTIES, INC.
RECONCILIATION OF NET INCOME TO NON-GAAP FINANCIAL MEASURES
(In thousands, except per share data)

2010 Guidance Reconciliation of Net Income to Adjusted Diluted FFO and FAD Per Share

	Year Ended December 31, 2010
	Guidance
	Low			High
Net income	$	153,069		$	155,568
Preferred stock dividends		—			—
Real estate related depreciation and amortization		127,737			127,737
Depreciation in income from unconsolidated joint ventures		4,766			4,766
Net income attributable to noncontrolling interests		(282	)		(282	)
Gains on sales of facilities, net		(10,783	)		(10,783	)
FFO available to common stockholders		274,507			277,006
Series B preferred dividends		—			—
Diluted FFO		274,507			277,006
Acquisition costs		3,070			3,070
Gain on extinguishment of debt		(75	)		(75	)
Gain on re-measurement of equity interest upon acquisition, net		(620	)		(620	)
Adjusted Diluted FFO		276,882			279,381
Straight-lined rent		(10,784	)		(10,784	)
Amortization of intangible assets and liabilities		(60	)		(60	)
Non-cash stock-based compensation expense		6,852			6,852
Deferred financing cost amortization		3,210			3,210
Lease commissions and tenant and capital improvements		(6,407	)		(6,407	)
Unconsolidated Joint Ventures:
Straight-lined rent		(1	)		(1	)
Deferred financing cost amortization		85			85
Adjusted Diluted FAD	$	269,777		$	272,276
Diluted FFO per share	$	2.21		$	2.23
Adjusted Diluted FFO per share	$	2.23		$	2.25
Adjusted Diluted FAD per share	$	2.17		$	2.19
Weighted average shares outstanding:
Diluted weighted average shares outstanding		121,921			121,921
NHP/PMB OP units		2,135			2,135
Total		124,056			124,056

10

NATIONWIDE HEALTH PROPERTIES, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands)

	June 30,			December 31,
	2010			2009
	(unaudited)
Assets
Investments in real estate:
Land	$	329,203		$	318,457
Buildings and improvements		3,505,002			3,088,183
		3,834,205			3,406,640
Less accumulated depreciation		(630,394	)		(585,294	)
		3,203,811			2,821,346
Mortgage loans receivable, net		200,241			110,613
Mortgage loan receivable from related party		—			47,500
Investments in unconsolidated joint ventures		46,469			51,924
Net real estate related investments		3,450,521			3,031,383
Cash and cash equivalents		172,570			382,278
Receivables, net		7,888			6,605
Asset held for sale		5,601			—
Intangible assets		147,943			93,657
Other assets		152,403			133,152
Total assets	$	3,936,926		$	3,647,075
Liabilities and Equity
Unsecured senior credit facility	$	—		$	—
Senior notes		991,633			991,633
Notes and bonds payable		533,525			431,456
Accounts payable and accrued liabilities		133,447			132,915
Total liabilities		1,658,605			1,556,004
Redeemable OP unitholder interests		78,898			57,335
Equity:
NHP stockholders’ equity:
Series B convertible preferred stock		—			51,364
Common stock		12,213			11,432
Capital in excess of par value		2,360,735			2,128,843
Cumulative net income		1,773,877			1,705,279
Accumulated other comprehensive loss		(2,477	)		(823	)
Cumulative dividends		(1,969,571	)		(1,862,996	)
Total NHP stockholders’ equity		2,174,777			2,033,099
Noncontrolling interests		24,646			637
Total equity		2,199,423			2,033,736
Total liabilities and equity	$	3,936,926		$	3,647,075

11

EX-99.2

Exhibit 99.2

Supplemental Information June 30, 2010

Disclaimer Certain information contained in this release includes forward-looking statements. Forward-looking statements include statements regarding our expectations, beliefs, intentions, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements which are not statements of historical facts. These statements may be identified, without limitation, by the use of forward-looking terminology such as "may," "will," "anticipates," "expects," "believes," "intends," "should" or comparable terms or the negative thereof. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those described in the statements. Risks and uncertainties associated with our business include (without limitation) the following: deterioration in the operating results or financial condition, including bankruptcies, of our tenants; non-payment or late payment of rent, interest or loan principal amounts by our tenants; our reliance on two tenants for a significant percentage of our revenue; occupancy levels at certain facilities; our level of indebtedness; changes in the ratings of our debt securities; maintaining compliance with our debt covenants; access to the capital markets and the cost and availability of capital; government regulations, including changes in the reimbursement levels under the Medicare and Medicaid programs; the general distress of the healthcare industry; increasing competition in our business sector; the effect of economic and market conditions and changes in interest rates; the amount and yield of any additional investments; risks associated with acquisitions, including our ability to identify and complete favorable transactions; delays or failures in obtaining third party consents or approvals; the failure to achieve perceived benefits; unexpected costs or liabilities and potential litigation; the ability of our tenants to pay contractual rent and/or interest escalations in future periods; the ability of our tenants to obtain and maintain adequate liability and other insurance; our ability to attract new tenants for certain facilities; our ability to sell certain facilities for their book value; our ability to retain key personnel; potential liability under environmental laws; the possibility that we could be required to repurchase some of our senior notes; the rights and influence of holders of our outstanding preferred stock; changes in or inadvertent violations of tax laws and regulations and other factors that can affect our status as a real estate investment trust; and other factors discussed from time to time in our news releases, public statements and/or filings with the Securities and Exchange Commission, especially the risk factors set forth in our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q. Forward-looking information is provided by us pursuant to the safe harbor established under the Private Securities Litigation Reform Act of 1995 and should be evaluated in the context of these factors. We disclaim any intent or obligation to update these forward-looking statements.

Contents Consolidated Income Statements Reconciliation of Net Income to Funds from Operations (FFO) Reconciliation of Net Income to Funds Available for Distribution (FAD) Reconciliation of 2010 Net Income Guidance to Adjusted Diluted FFO and Diluted FAD Guidance Consolidated Balance Sheets Other Assets Capitalization Debt Maturities and Debt Composition Debt Covenants: Credit Facility & Bond Covenants Interest and Fixed Charge Coverage Unconsolidated Joint Venture Financial Statements - Financial Measures Definition 2nd Quarter 2010 Investments Year to Date June 30, 2010 Investments Rent Loss from Dispositions and Lease Restructuring Projected Funding Obligations through 2012 Triple-Net Lease Expirations and Mortgage Loans Receivable Principal Payments Portfolio Summary Consolidated Portfolio Performance Metrics-Same Store and Total Consolidated Non-Stabilized Portfolio Performance by Asset Type Tenant Benchmarks Geographic Benchmarks Unconsolidated JV Portfolio Performance Metrics Medical Office Building Portfolio Performance Metrics Medical Office Building Lease Expirations and Mortgage Loan Receivable Principal Payments Medical Office Building Leasing Activity - Portfolio Performance Measures Definitions FINANCIAL RESULTS INVESTMENT & DISPOSITION PORTFOLIO OVERVIEW COMPANY FACT SHEET 3 4 24 36

Company Fact Sheet REIT structure provides opportunity to invest directly in real estate and indirectly in healthcare industry Quality healthcare real estate portfolio Long-term triple-net master leases with quality operators Strong affiliations with premiere hospital systems in growing medical office building markets Senior housing care a vital component of U.S. economy High dividend yield and high dividend coverage Financial stability Well positioned to take advantage of investment opportunities and to conservatively grow earnings and dividends NHP is one of the few healthcare REITs with investment grade ratings by Fitch, Moody's, and Standard & Poors. Nationwide Health Properties, Inc. (NHP), incorporated in October 1985, is a publicly traded real estate investment trust (REIT) that invests in senior housing facilities, long-term care facilities and medical office buildings throughout the United States. NHP generally acquires real estate and then leases the assets under long-term triple-net master leases to senior housing and long-term care operators and various types of leases to multiple tenants in the case of medical office buildings. As a REIT specializing in healthcare real estate, NHP provides a focused investment strategy with a well diversified portfolio. NHP employs a conservative, long-term approach to real estate investments with an experienced professional management team having extensive operating, real estate and finance backgrounds. $4.8 billion in healthcare real estate 628 properties in 43 states 265 Assisted and Independent Living 192 Skilled Nursing 120 Medical Office Buildings 17 Other 34 Unconsolidated JV Facilities Over 80 multi-facility tenants Market Facts Enterprise Value $5.9 billion Closing Price $35.77 Market Capitalization $4.4 billion Dividend & Yield $1.80 (5.0%) 52 week range $24.51 - $37.18 Shares & OP Units 124.3 million Company Profile Investor Highlights Our Portfolio WI (6%) WA (5%) CA (17%) TX (14%) Credit Ratings Fitch BBB (stable) Moody's Baa2 (stable) S&P BBB (stable) as of June 30, 2010 as of June 30, 2010 FL (6%)

FINANCIAL RESULTS

Consolidated Income Statements

Reconciliation of Net Income to Funds From Operations (FFO) See Financial Measures Definitions

Reconciliation of Net Income to Funds Available for Distribution (FAD) See Financial Measures Definitions

Reconciliation of 2010 Net Income Guidance to Diluted FFO and Diluted FAD Guidance See Financial Measures Definitions

Consolidated Balance Sheets

Other Assets

Capitalization

Capitalization (2) MOBs NHP/PMB 62 NHP/PMB Under Contruction 38 Equity Debt Investments 64 36 MrktCap TotDebt Investments 73 27 Undepreciated Book Basis Enterprise Value 64% Equity 36% Debt 73% Equity 27% Debt 62% 38% MOBs NHP/PMB 93 NHP/PMB Under Contruction 7 93% 7% Unsecured Secured Fixed Variable Debt Composition Based on total debt including NHP's share of unconsolidated joint venture

Debt Maturities and Debt Composition

Debt Covenants

Credit Facility Covenants

Bonds Covenants (Bonds Issued Prior to 2006)

New Bond Covenants (Bonds Issued After 2006)

Interest and Fixed Charge Coverage See Financial Measures Definitions

Unconsolidated Joint Venture Financial Statements - Balance Sheet

Unconsolidated Joint Venture Financial Statements - Income Statements

Financial Measures Definitions Adjusted EBITDA: We believe that Adjusted EBITDA is an important supplemental operating and liquidity measure primarily because it is used in the calculation of the Adjusted Interest Coverage Ratio and the Adjusted Fixed Charge Coverage Ratio and we present it solely for the purpose of being used in those calculations. Adjusted EBITDA is calculated by adding back any gains and losses on the sale of real estate and any impairments to EBITDA for a given period. We believe Adjusted EBITDA is most useful as a liquidity measure in the ratio calculations noted above to enable investors to determine and compare a company's ability to meet its interest and Fixed Charges obligations. However, the methodology for calculating it makes net income the most directly comparable GAAP measure. As such, we believe investors should consider Adjusted EBITDA, cash flows from operating activities and net income when evaluating our ability to meet our interest and Fixed Charges obligations. The usefulness of Adjusted EBITDA is limited because it doesn't reflect, among other things, required principal payments, cash expenditures, capital expenditures or capital commitments. Adjusted EBITDA does not represent net income or cash flows from operations as defined by GAAP and should not be considered as an alternative to either of those measures. Our calculation of Adjusted EBITDA may not be comparable to similar measures reported by other companies. Adjusted Fixed Charge Coverage Ratio: We believe that the Adjusted Fixed Charge Coverage Ratio is an important supplemental liquidity measure that reflects a company's ability to meet its interest and preferred dividend payment obligations and allows investors to compare interest and dividend paying capabilities among different companies. We calculate the Adjusted Fixed Charge Coverage Ratio by dividing Adjusted EBITDA by Fixed Charges. In addition, credit rating agencies utilize similar ratios in evaluating the credit ratings on our debt instruments. This ratio's usefulness is limited by the same factors that limit the usefulness of the components Adjusted EBITDA and Fixed Charges. Our calculation of the Adjusted Fixed Charge Coverage Ratio should not be considered an alternative to the ratio of earnings to fixed charges as defined by Item 503(d) of Regulation S-K and it may not be comparable to similar ratios reported by other companies. Adjusted Interest Coverage Ratio: We believe that the Adjusted Interest Coverage Ratio is an important supplemental liquidity measure that reflects a company's ability to meet its interest payment obligations and allows investors to compare interest paying capabilities among different companies. We calculate the Adjusted Interest Coverage Ratio by dividing Adjusted EBITDA by interest expense (including capitalized interest, if any). In addition, credit rating agencies utilize similar ratios in evaluating the credit ratings on our debt instruments. This ratio's usefulness is limited by the same factors that limit the usefulness of the component Adjusted EBITDA. Our calculations of the Adjusted Interest Coverage Ratio may not be comparable to similar ratios reported by other companies. EBITDA: We believe that EBITDA is an important supplemental operating and liquidity measure primarily because it is used in the calculation of Adjusted EBITDA which is in turn used in the calculation of the Adjusted Interest Coverage Ratio and the Adjusted Fixed Charge Coverage Ratio and we present it solely for the purpose of being used in those calculations. EBITDA is calculated by adding interest, taxes, depreciation and amortization to net income. The real estate industry uses EBITDA as a non-GAAP measure of both operating performance and liquidity. We believe it is most useful as a liquidity measure in the ratio calculations noted above to enable investors to determine and compare a company's ability to meet its interest and Fixed Charges obligations. However, the methodology for calculating it makes net income the most directly comparable GAAP measure. As such, we believe investors should consider EBITDA, cash flows from operating activities and net income when evaluating our ability to meet our interest and Fixed Charges obligations. The usefulness of EBITDA is limited because it doesn't reflect, among other things, required principal payments, cash expenditures, capital expenditures or capital commitments. EBITDA does not represent net income or cash flows from operations as defined by GAAP and should not be considered as an alternative to either of those measures. Our calculation of EBITDA may not be comparable to similar measures reported by other companies.

Financial Measures Definitions (2) FAD Payout Ratio and FFO Coverage: The FAD Payout Ratio is calculated by dividing the common dividend per share by diluted FAD per share for any given period. FAD Coverage is calculated by dividing diluted FAD per share by the common dividend per share for any given period. We believe that both of these amounts are important supplemental liquidity measures that enable investors to compare dividend security among REITs. Fixed Charges: Fixed Charges is a measure of the total interest and preferred stock dividend obligations of a company. It is calculated by adding interest expense (including capitalized interest, if any) and preferred stock dividends for any given period and is utilized in calculating the Adjusted Fixed Charge Coverage Ratio. It's usefulness is limited as, among other things, it does not include required principal payments or any other contractual obligations a company may have. Our calculation of Fixed Charges should not be considered an alternative to fixed charges as defined by Item 503(d) of Regulation S-K and it may not be comparable to Fixed Charges reported by other companies. Funds Available for Distribution ("FAD"): While net income and its related per share amounts, as defined by accounting principles generally accepted in the United States ("GAAP"), are the most appropriate earnings measures, we believe that FAD and the related per share amounts are important non-GAAP supplemental measures of operating performance. GAAP requires the use of straight- line depreciation of historical costs and implies that real estate values diminish predictably and ratably over time. However, real estate values have historically risen and fallen based on various market conditions and other factors. FFO was developed as a supplemental measure of operating performance primarily in order to exclude historical cost-based depreciation and amortization and its effects as it does not generally reflect the actual change in value of real estate over time. FAD was developed as a supplemental measure of operating performance primarily to exclude non-cash revenues and expenses that are included in FFO. FAD is defined as net income (computed in accordance with GAAP) excluding gains and losses from the sale of real estate plus real estate related depreciation and amortization, plus or minus straight-lined rent (plus cash in excess of rent or minus rent in excess of cash), plus or minus amortization of above or below market lease intangibles, plus non-cash stock based compensation, plus deferred financing cost amortization plus any impairments minus lease commissions, tenant improvements and capital improvements paid. The same adjustments are made to reflect our share of these same items from unconsolidated joint ventures. We believe that the use of FAD and the related per share amounts in conjunction with the required GAAP disclosures provides investors with a more comprehensive understanding of the operating results of a real estate investment trust ("REIT") and enables investors to compare the operating results between REITs without having to account for differences caused by different depreciation assumptions and different non-cash revenues and expenses. Additionally, FAD is used by us and widely used by industry analysts as a measure of operating performance for equity REITs. Our calculations of FAD and the related per share amounts presented herein may not be comparable to similar measures reported by other REITs that do not use the same definitions as we do for these terms. These supplemental reporting measures should not be considered as alternatives to net income (a GAAP measure) as primary indicators of our financial performance or as alternatives to cash flow from operating activities (a GAAP measure) as primary measures of our liquidity, nor are these measures necessarily indicative of sufficient cash flow to satisfy all of our liquidity requirements. Adjusted FAD: Adjusted FAD is defined as FAD excluding acquisition costs and gains and losses other than those from the sale of real estate. Funds From Operations ("FFO"): While net income and its related per share amounts, as defined by accounting principles generally accepted in the United States ("GAAP"), are the most appropriate earnings measures, we believe that FFO and the related per share amounts are important non-GAAP supplemental measures of operating performance. GAAP requires the use of straight- line depreciation of historical costs and implies that real estate values diminish predictably and ratably over time. However, real estate values have historically risen and fallen based on various market conditions and other factors. FFO was developed as a supplemental measure of operating performance primarily in order to exclude historical cost-based depreciation and amortization and its effects as it does not generally reflect the actual change in value of real estate over time. We calculate FFO in accordance with the National Association of Real Estate Investment Trusts' definition. FFO is defined as

Financial Measures Definitions (3) net income (computed in accordance with GAAP) excluding gains and losses from the sale of real estate plus real estate related depreciation and amortization. The same adjustments are made to reflect our share of these same items from unconsolidated joint ventures. We believe that the use of FFO and the related per share amounts in conjunction with the required GAAP disclosures provides investors with a more comprehensive understanding of the operating results of a real estate investment trust ("REIT") and enables investors to compare the operating results between REITs without having to account for differences caused by different depreciation assumptions. Additionally, FFO is used by us and widely used by industry analysts as a measure of operating performance for equity REITs. Our calculations of FFO and the related per share amounts presented herein may not be comparable to similar measures reported by other REITs that do not define FFO in accordance with the NAREIT definition, interpret that definition differently than we do or that do not use the same definitions as we do for such terms. These supplemental reporting measures should not be considered as alternatives to net income (a GAAP measure) as primary indicators of our financial performance or as alternatives to cash flow from operating activities (a GAAP measure) as primary measures of our liquidity, nor are these measures necessarily indicative of sufficient cash flow to satisfy all of our liquidity requirements. Adjusted FFO: Adjusted FFO is defined as FFO excluding impairments of assets, acquisition costs and gains and losses other than those from the sale of real estate. Enterprise Value: Enterprise Value is a measure of a company's value. We calculate Enterprise Value as market equity capitalization plus debt. Market equity capitalization is calculated as the sum of (1) the number of shares of common stock and limited partnership units multiplied by the closing price of our common stock on the last day of the period presented and (2) the number of shares of Series B preferred stock multiplied by the closing price of our Series B preferred stock on the last day of the period presented. Consolidated Enterprise Value includes our market equity capitalization, noncontrolling interests and consolidated debt, less cash and cash equivalents. Total Enterprise Value includes our market equity capitalization, noncontrolling interests, and consolidated debt, less cash and cash equivalents and our share of the debt of our unconsolidated joint ventures, less our share of the cash and cash equivalents of our unconsolidated joint ventures. Gross Investment: We define Gross Investment as our total investment in a property which includes land, building, improvements, equipment as well as any other identifiable assets such as lease-up intangible assets, above market tenant and ground lease intangible assets (collectively "intangible assets") included on our balance sheets and/or below market tenant and ground lease intangible liabilities included in the caption "Accounts Payable and Accrued Liabilities" on our balance sheets.

INVESTMENTS & DISPOSITIONS

2nd Quarter 2010 Investments

MOB ACQUISITION | ProHealth (April 2010) Location Wisconsin Wisconsin Key Stats Purchase Price: $43M Price per SQFT: $169 Lease: Triple Net Facility Type: MOB Average Age: 9 years No. of Facilities: 7 Rentable Square Feet: 256,000 Occupancy: 100%

SNF ACQUISITION | Mission Healthcare (April 2010) Location South Dakota South Dakota Key Stats Purchase Price: $9M Price per Bed: $62K Lease: Triple Net Facility Type: SNF Age: 44 years (renovated in 1995) No. of Facilities: 1 No. of Beds: 146 Occupancy: 98% Q-mix: 44.2%

ALF ACQUISITION | Azura Healthcare (May 2010) Location Wisconsin Wisconsin Key Stats Purchase Price: $6M Price per Bed: $65K Lease: Triple Net Facility Type: ALF Age: 14 years No. of Facilities: 5 No. of Units: 93 Occupancy: 78%

SNF ACQUISITION | Healthmark (June 2010) Location Texas Texas Key Stats Purchase Price: $85M Price per Bed: $114K Lease: Triple Net Facility Type: SNF Age: 8 years No. of Facilities: 6 No. of Beds: 745 Occupancy: 84% Q-mix: 66%

SNF ACQUISITION | Senior Care Centers (June 2010) Location Texas Texas Key Stats Purchase Price: $36M Price per Bed: $89K Lease: Triple Net Facility Type: SNF Age: 11 years No. of Facilities: 4 No. of Beds: 402 Occupancy: 82% Q-mix: 57%

Year to Date June 30, 2010 Investments

Rent Loss from Dispositions and Lease Restructuring

Projected Funding Obligations through 2012 (as of June 30, 2010)

Conditional Pacific Medical Buildings Acquisition Obligations through 2012 (as of June 30, 2010)

Triple-Net Lease Expirations and Mortgage Loans Receivable Principal Payments

PORTFOLIO OVERVIEW

Portfolio Summary

Portfolio Performance Summary

Portfolio Overview Private Pay Medicare Medicaid Investments 73 10 17 Asset Type Pay Source Locations Tenant/Operator (based on investment) (based on investment*) (based on revenue) *Investment includes all asset types Private Pay 73% Medicaid 17% Medicare 10% Skilled Assissted Other MOBs Investments 26 42 5 27 Independent and Assisted Living 42% Skilled Nursing 26% MOBs 27% Other 5% WA (5%) CA (17%) WI (6%) TX (14%) Top 5 = 36% Top 10 = 49% Top 15 = 56% FL (6%)

Consolidated Portfolio Performance by Asset Type

Consolidated Portfolio Performance

Consolidated Non-Stabilized Portfolio Performance by Asset Type

Tenant Concentration

Geographic Performance Metrics

Geographic Performance Metrics

Portfolio Performance Summary | Asset Class Composition Trends (by Investment)

Portfolio Performance Summary | Private Pay Composition Trends (by Revenue)

Portfolio Performance Summary | Top Tenant Concentration Trends (by Revenue)

Unconsolidated JV Portfolio Performance Metrics

Medical Office Building Portfolio Performance Metrics

Medical Office Building Lease Expirations and Mortgage Loan Receivable Principal Payments

Medical Office Building Leasing Activity General Notes: 3/31/10 Leased Square Feet adjusted at start of Q2 to include Q2 2010 acquisitions. Unresolved MTM Leases excluded from Expirations column.

Portfolio Performance Measures Definitions Annualized Cash Rent/NOI: The total cash rent due from our tenants is based on the trailing twelve- month period one month in arrears from the period presented. For our medical office building portfolio, NOI is equal to the actual year to date NOI for the period presented plus the forecasted NOI for the remainder of the calendar year. We use Annualized Cash Rent to calculate our EBITDARM, EBITDAR and EBITDAR - Capex coverages. Facility EBITDAR: Earnings before interest, taxes, depreciation, amortization and rent on an annualized basis. We believe EBITDAR is a good estimate of facility cash flows after payment of management fees. We use a standardized imputed management fee equal to 5% of the revenues our tenants or borrowers generate at each individual facility (Facility Revenues) which we believe represents typical management fees for our senior housing and long-term care portfolios. We receive periodic facility financial information from our tenants that we utilize to calculate EBITDAR. EBITDAR figures are based on the trailing twelve-month period one month in arrears from the period presented. All facility financial information was derived solely from information provided by our tenants and borrowers and we have not verified such information. We use EBITDAR to calculate the EBITDAR (cash flow) coverage for our portfolio. Facility EBITDAR Coverage: Annualized EBITDAR divided by Annualized Cash Rent. This ratio is a measure of a facility's ability to cover its cash rent obligations. EBITDAR Coverage of 1.0X would indicate the EBITDAR is just sufficient to pay the cash rent. The higher the coverage, the better able a facility is to meet its rent obligations. This is the mid-range coverage calculation we utilize. Facility EBITDARM: Earnings before interest, taxes, depreciation, amortization, rent and management fees based on the trailing twelve-month period one month in arrears from the period presented. We believe EBITDARM is a good estimate of facility cash flows before payment of management fees. We use a standardized imputed management fee equal to 5% of the revenues our tenants or borrowers generate at each individual facility (Facility Revenues) which we believe represents typical management fees for our senior housing and long-term care portfolios. We receive periodic facility financial information from our tenants that we utilize to calculate EBITDARM. All facility financial information was derived solely from information provided by our tenants and borrowers and we have not verified such information. We use EBITDARM to calculate the EBITDARM (cash flow before management fee) coverage for our portfolio. Facility EBITDARM Coverage: Annualized EBITDARM divided by Annualized Cash Rent. This ratio is a measure of a facility's ability to cover its cash rent obligations assuming it doesn't have to pay its management fee. EBITDARM Coverage of 1.0X would indicate the EBITDARM is just sufficient to pay the cash rent. The higher the coverage, the better able a facility is to meet its rent obligations. This is the least restrictive coverage measure we utilize. Facility EBITDAR - Capex: Earnings before interest, taxes, depreciation, amortization and rent less minimum capital expenditures (capex) based on the trailing twelve-month period one month in arrears from the period presented. We believe EBITDAR is a good estimate of facility cash flows after a reserve for minimum capital expenditures required to maintain a facility. We use a standardized imputed capital expenditure schedule in our calculations based on the type, size and age of each facility which we believe represents typical minimum capital expenditures for our senior housing and long-term care portfolios. We receive periodic facility financial information from our tenants that we utilize to calculate EBITDAR - Capex. All facility financial information was derived solely from information provided by our tenants and borrowers and we have not verified such information. We use EBITDAR - Capex to calculate the EBITDAR - Capex (cash flow after reserves for minimum capex requirements) coverage for our portfolio. Facility EBITDAR - Capex Coverage: Annualized EBITDAR - Capex divided by Annualized Cash Rent. This ratio is a measure of a facility's ability to cover its cash rent obligations after it makes the minimum capital expenditures required to maintain the facility. EBITDAR - - Capex Coverage of 1.0X would indicate the EBITDAR - Capex is just sufficient to pay the cash rent. The higher the coverage, the better able a facility is to meet its rent obligations. This is the most restrictive coverage measure we utilize. Facility Revenues: Except for medical office buildings, the revenues generated by each individual facility are based on the trailing twelve-month period one month in

Portfolio Performance Measures Definitions (2) arrears from the period presented. We receive periodic facility financial information from our tenants that we utilize to calculate Facility Revenues. All facility financial information was derived solely from information provided by our tenants and borrowers and we have not verified such information. Annualized Revenue: For medical office buildings, the revenue is equal to the actual year to date revenue for the period presented plus the forecasted revenue for the remainder of the calendar year. Gross Investment: We define Gross Investment as our total investment in a property which includes land, building, improvements, equipment as well as any other identifiable assets included in the caption Other Assets on our balance sheets. Items classified in Other Assets generally pertain to our medical office buildings and may include such things as tenant improvements, leasing commissions, above/(below) market lease value, lease in place value and other items. Monthly Revenue per Occupied Bed/Unit: For our senior housing and long-term care portfolio, monthly revenue per occupied bed or unit is derived by determining the revenue generated by each individual facility divided by the total number of actual resident days, each of which is based on the trailing twelve-month period one month in arrears from the period presented, with the resulting quotient multiplied by 30.41667. All facility performance data were derived solely from information provided by our tenants and borrowers and we have not verified such information. Occupancy: For our senior housing and long-term care portfolio, the occupancy reported is one month in arrears from the period presented and represents a facility's actual resident days (total number of beds or units occupied multiplied by the number of days in the period) divided by the total resident capacity (total number of beds or units in service for the period multiplied by the number of days in the period). For medical office buildings, facility occupancy reported is as of the period presented and represents the leased square feet divided by the total rentable square feet. All facility performance data were derived solely from information provided by our tenants, borrowers, and property managers and we have not verified such information. NOI: Net operating income ("NOI") is a non-GAAP supplemental financial measure used to evaluate the operating performance of our facilities. We define NOI for our triple-net leases segment as rent revenues. For our medical office building segment, we define NOI as revenues minus medical office building operating expenses. In some cases, revenue for medical office buildings includes expense reimbursements for common area maintenance charges. NOI excludes interest expense, non-operating expenses, amortization of deferred financing costs, depreciation and amortization expense, and discontinued operations. We present NOI as it effectively presents our portfolio on a "net" rent basis and provides relevant and useful information as it measures the operating performance at the facility level on an unleveraged basis. We use NOI to make decisions about resource allocations and to assess the property level performance of our properties. Furthermore, we believe that NOI provides investors relevant and useful information because it measures the operating performance of our real estate at the property level on an unleveraged basis. We believe that net income is the GAAP measure that is most directly comparable to NOI. However, NOI should not be considered as an alternative to net income as the primary indicator of operating performance as it excludes the items described above. Additionally, NOI as presented above may not be comparable to other REITs or companies as their definitions of NOI may differ from ours. Q-Mix: For our long-term care portfolio, Q-Mix (abbreviation for Quality-Mix) refers to the combination of a Tenant's private and medicare revenues as a percentage of total revenues. As private and medicare rates are generally higher at long-term care facilities, Tenants can oftentimes improve margins by selectively targeting medicare and private-pay residents. As such, an increase in the Q-Mix generally results in a corresponding increase in a Tenant's total revenues. Rentable Square Feet: For our medical office building portfolio, rentable square feet represents the area measured to the inside finished surface of the dominant portion of the permanent outer building walls, excluding any major vertical penetrations of the floor. An add-on or load factor is used to charge the tenant for a percentage of the common areas, so that the total rentable square footage for the building is equal to sum of each floor's rentable area.

Portfolio Performance Measures Definitions (3) Same Property (Performance): Results shown under the Same Property caption present the financial or other performance measures for only those facilities that were in our portfolio for more than twelve month at the end of all periods presented.